Capsule Endoscopy System Tech Support Promo Box
Technical support
Get technical support for all gastrointestinal and hepatology products.
Email us
Phone: 1-800-448-3644, option 3
Reflux testing systems
Bravo™ calibration-free reflux testing system
Reflux testing systems
Bravo™ calibration-free reflux testing system
The Bravo™ calibration-free reflux testing system is a capsule-based testing system used to determine if acid reflux is causing the patient's symptoms.
Description
Measure and monitor gastroesophageal pH with Bravo™
The Bravo™ calibration-free reflux testing system provides information to help establish the GERD diagnosis.1
- Up to 70% of patients with GERD do not have evidence of erosive changes on endoscopy.2
- The system provides greater sensitivity than endoscopy and higher specificity than therapeutic trials with Proton-pump inhibitors (PPIs).1
- Patients maintain regular diet and activities during the procedure, so testing is done under normal physiologic conditions.3
- Tolerance and satisfaction with catheter-free pH monitoring are high in patients who had previously failed catheter-based pH; catheter-free pH monitoring assists in the definitive diagnosis of GERD in this group.4
Features
Discover the Bravo™ calibration-free reflux testing system.
1 in 3 patients referred with ongoing symptoms while using PPIs doesn't have gerd.5
There are many recent advances in the diagnosis and management of GERD. Prolonged wireless pH monitoring has value on clinical reflux monitoring to enable the assessment of predominant exposure patterns and aid in the diagnosis of GERD.1
- Learn more about the benefits of 96-hour reflux monitoring. View clinical summary.
- See the current GERD diagnosis and management guidelines from the American College of Gastroenterology and the American Gastroenterology Association.
Among patients with heartburn, endoscopy with ambulatory reflux monitoring (off PPI) optimizes cost-effective management.6
The most cost-effective diagnostic approach to managing patients with typical GERD symptoms of heartburn that lack alarm symptoms and fail an empiric PPI is to offer endoscopy with ambulatory reflux monitoring followed by a trial of PPI discontinuation for patients without erosive findings.6
See the current GERD diagnosis and management guidelines from the American College of Gastroenterology and the American Gastroenterology Association.
Featured education
GERD and esophageal motility disorders
Advance your understanding of GERD and esophageal motility disorders including diagnostic workup and subsequent treatment considerations.
Bravo™ reflux testing: a clinical story
Get a high-level overview of esophageal reflux testing modalities.
Software updates
Contact a representative to download the latest reflux reader software.
Ordering information
Resources
Related links
Similar products
- Hirano I, Zhang Q, Pandolfino JE, Kahrilas PJ. Four-day Bravo™ reflux testing system pH capsule monitoring with and without proton pump inhibitor therapy. Clin Gastroenterol and Hepatol. 2005;3(11):1083–1088.
- Vaezi M, Zehrai A, and Yuksel E. Testing for refractory gastroesophageal reflux disease. American Society for Gastrointestinal Endoscopy ASGE Leading Edge. 2012;2(2):1–13.
- Tseng D, Rizvi AZ, Fennerty MB, et al. Forty-eight hour pH monitoring increases sensitivity in detecting abnormal esophageal acid exposure. J Gastro Surgery. 2005;9(8):1043–1052.
- Sweiss R, Fox M, Anggiansah R, et al. Patient acceptance and clinical impact of Bravo™ monitoring in patients with previous failed catheter-based studies. Aliment Pharmacology and Therapeutics. 2009;29(6):669–676.
- Herregods TV, Troelstra M, Weijenborg PW, Bredenoord AJ, Smout AJ. Patients with refractory reflux symptoms often do not have GERD. Neurogastroenterol Motil. 2015;27(9):1267–1273.